Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001628280-24-052347

Chief Executive Officer sold 12,563 shares at $19.59 ($246,109)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Anzalone Christopher Richard Chief Executive Officer 2024-12-23 Sale 10b5-1 −12,563 $19.59 $246,109 3,775,772 D
Open-market sales · 12,563 sh · avg $19.59 · $246,109
Loading xslF345X05/wk-form4_1734989985.xml…